Company Filing History:
8 out of 41 
5 out of 3,539 
Years Active: 2018-2025
Title: The Innovative Contributions of Adrian I Bot
Introduction
Adrian I Bot is a prominent inventor based in Santa Monica, California, known for his significant contributions to the field of immunotherapy. With a total of seven patents to his name, he has made remarkable strides in the treatment of malignancies through advanced T cell therapies.
Latest Patents
Among his latest patents is a groundbreaking method for chimeric antigen receptor T cell therapy. This patent outlines methods for treating malignancies by administering an effective dose of genetically modified T cell immunotherapy. It also includes innovative approaches for determining a patient's objective response to the therapy based on specific attributes measured before and after treatment. Another notable patent focuses on chimeric receptor T cell treatment, utilizing characteristics of the tumor microenvironment. This patent provides methods for characterizing the pre-infusion tumor microenvironment and determining the effective dose of T cell immunotherapy.
Career Highlights
Adrian has worked with leading organizations in the field, including Kite Pharma, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has been instrumental in advancing the understanding and application of T cell therapies in clinical settings.
Collaborations
Throughout his career, Adrian has collaborated with esteemed colleagues such as Jeffrey S Wiezorek and William Go. These partnerships have further enhanced the impact of his research and innovations in immunotherapy.
Conclusion
Adrian I Bot's contributions to the field of immunotherapy are significant and continue to influence the treatment of malignancies. His innovative patents and collaborations reflect his dedication to advancing medical science and improving patient outcomes.